sEH inhibitor-19 (Compound (R)-14i) is an orally active inhibitor for soluble epoxide hydrolase ( sEH ) with an IC 50 of 1.2 nM. sEH inhibitor-19 inhibits the expression of TNF-α and IL-6 , exhibits anti-inflammatory activity in mouse acute pancreatitis or Carrageenan ( HY-125474 )-induced edema models.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Epoxide Hydrolase | Products > Signaling Pathways > Interleukin Related | Products > Signaling Pathways > TNF Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.